Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1991 May;73(1):58–63.

Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin.

N Hunter 1, K M Weston 1, N A Bowern 1
PMCID: PMC1384518  PMID: 1710603

Abstract

Lewis rats sensitized with guinea-pig spinal cord in Freund's complete adjuvant developed an acute-phase protein response. This was characterized by a marked increase in plasma alpha 2-macroglobulin (alpha 2 M) levels which, however, declined towards normal values before the onset of clinical signs of experimental allergic encephalomyelitis (EAE). In contrast, levels of two other acute-phase proteins, fibrinogen and caeruloplasmin, remained variably elevated over the entire study period. Recovery from EAE coincided with an increase in alpha 2 M levels. Infusion of purified alpha 2 M effectively protected the rats against clinical EAE and this was associated with a restimulation of the acute-phase response. The protected rats were shown to be sensitized to myelin basic protein and to have comparable mononuclear infiltration of the central nervous system with the diseased animals. It is postulated that the infusion of alpha 2 M leads to the inhibition of the effector pathways of the delayed type hypersensitivity response.

Full text

PDF
58

Images in this article

61Figure 5
on p.61

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldo B. A., Chow S. C., Euers C. A new screen for anti-inflammatory agents. Estimation of rat serum acute phase alpha2-macroglobulin levels using an electroimmunoassay. Agents Actions. 1981 Nov;11(5):482–489. doi: 10.1007/BF02004710. [DOI] [PubMed] [Google Scholar]
  2. Bernard C. C., Lamoureux G. Inhibition by serum of encephalitogenic activity of myelin basic protein: nature of the serum factor responsible. Cell Immunol. 1975 Mar;16(1):182–191. doi: 10.1016/0008-8749(75)90197-5. [DOI] [PubMed] [Google Scholar]
  3. Borth W., Teodorescu M. Inactivation of human interleukin-2 (IL-2) by alpha 2-macroglobulin-trypsin complexes. Immunology. 1986 Mar;57(3):367–371. [PMC free article] [PubMed] [Google Scholar]
  4. Bowern N., Ramshaw I. A., Clark I. A., Doherty P. C. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med. 1984 Nov 1;160(5):1532–1543. doi: 10.1084/jem.160.5.1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brosnan C. F., Cammer W., Norton W. T., Bloom B. R. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature. 1980 May 22;285(5762):235–237. doi: 10.1038/285235a0. [DOI] [PubMed] [Google Scholar]
  6. Chlebowski J. F., Williams K. Isolation of active subforms of alpha 2-macroglobulin. Biochem J. 1985 Jul 1;229(1):227–232. doi: 10.1042/bj2290227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deibler G. E., Martenson R. E., Kies M. W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem. 1972;2(2):139–165. doi: 10.1080/00327487208061467. [DOI] [PubMed] [Google Scholar]
  8. Frénoy J. P., Bourrillon R. Studies on the structure of human alpha2-macroglobulin. IV. Analysis of the microheterogeneity by isoelectric focusing. Biochim Biophys Acta. 1974 Nov 5;371(1):168–176. doi: 10.1016/0005-2795(74)90166-4. [DOI] [PubMed] [Google Scholar]
  9. Gerstl B., Uyeda C. T., Hunt H., Eng L. F. A physiological mechanism preventing experimental allergic encephalitis. Immunology. 1972 Sep;23(3):395–403. [PMC free article] [PubMed] [Google Scholar]
  10. Gordon A. H. The alpha macroglobulins of rat serum. Biochem J. 1976 Dec 1;159(3):643–650. doi: 10.1042/bj1590643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Heim W. G. Relation between rat slow alpha-2-globulin and alpha-2-macroglobulin of other mammals. Nature. 1968 Mar 16;217(5133):1057–1059. doi: 10.1038/2171057a0. [DOI] [PubMed] [Google Scholar]
  12. Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990 Feb 1;265(3):621–636. doi: 10.1042/bj2650621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hoffman M. R., Pizzo S. V., Weinberg J. B. Modulation of mouse peritoneal macrophage Ia and human peritoneal macrophage HLA-DR expression by alpha 2-macroglobulin "fast" forms. J Immunol. 1987 Sep 15;139(6):1885–1890. [PubMed] [Google Scholar]
  14. Hoffman M., Feldman S. R., Pizzo S. V. Alpha 2-macroglobulin 'fast' forms inhibit superoxide production by activated macrophages. Biochim Biophys Acta. 1983 Nov 8;760(3):421–423. doi: 10.1016/0304-4165(83)90384-7. [DOI] [PubMed] [Google Scholar]
  15. Johnson W. J., Pizzo S. V., Imber M. J., Adams D. O. Receptors for maleylated proteins regulate secretion of neutral proteases by murine macrophages. Science. 1982 Nov 5;218(4572):574–576. doi: 10.1126/science.6289443. [DOI] [PubMed] [Google Scholar]
  16. Levine S., Sowinski R., Steinetz B. Effects of experimental allergic encephalomyelitis on thymus and adrenal: relation to remission and relapse. Proc Soc Exp Biol Med. 1980 Nov;165(2):218–224. doi: 10.3181/00379727-165-40961. [DOI] [PubMed] [Google Scholar]
  17. Lukens J. N., Cartwright G. E., Wintrobe M. M. Anemia of adjuvant-induced inflammation in rats. Proc Soc Exp Biol Med. 1967 Nov;126(2):346–349. doi: 10.3181/00379727-126-32441. [DOI] [PubMed] [Google Scholar]
  18. Mannhalter J. W., Borth W., Eibl M. M. Modulation of antigen-induced T cell proliferation by alpha 2M-trypsin complexes. J Immunol. 1986 Apr 15;136(8):2792–2799. [PubMed] [Google Scholar]
  19. Mason D., MacPhee I., Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology. 1990 May;70(1):1–5. [PMC free article] [PubMed] [Google Scholar]
  20. McPherson T. A., Marchalonis J. J., Lennon V. Binding of encephalitogenic basic protein by serum alpha-globulins. Immunology. 1970 Dec;19(6):929–933. [PMC free article] [PubMed] [Google Scholar]
  21. Nieuwenhuizen W., Emeis J. J., Hemmink J. Purification and properties of rat alpha 2 acute-phase macroglobulin. Biochim Biophys Acta. 1979 Sep 29;580(1):129–139. doi: 10.1016/0005-2795(79)90204-6. [DOI] [PubMed] [Google Scholar]
  22. Northemann W., Shiels B. R., Braciak T. A., Hanson R. W., Heinrich P. C., Fey G. H. Structure and acute-phase regulation of the rat alpha 2-macroglobulin gene. Biochemistry. 1988 Dec 27;27(26):9194–9203. doi: 10.1021/bi00426a018. [DOI] [PubMed] [Google Scholar]
  23. PEARSON C. M., WAKSMAN B. H., SHARP J. T. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease. J Exp Med. 1961 Mar 1;113:485–510. doi: 10.1084/jem.113.3.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Paterson P. Y., Drobish D. G., Hanson M. A., Jacobs A. F. Induction of experimental allergic encephalomyelitis in Lewis rats. Int Arch Allergy Appl Immunol. 1970;37(1):26–40. doi: 10.1159/000230217. [DOI] [PubMed] [Google Scholar]
  25. RAVIN H. A. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med. 1961 Jul;58:161–168. [PubMed] [Google Scholar]
  26. Wycoff H. D. Production of fibrinogen following an endotoxin injection. Proc Soc Exp Biol Med. 1970 Mar;133(3):940–943. doi: 10.3181/00379727-133-34599. [DOI] [PubMed] [Google Scholar]
  27. ZENKER N., BERNSTEIN D. E. The estimation of small amounts of corticosterone in rat plasma. J Biol Chem. 1958 Apr;231(2):695–701. [PubMed] [Google Scholar]
  28. van Gool J., Schreuder J., Ladiges N. C. Inhibitory effect of foetal alpha 2 globulin, an acute phase protein, on carrageenin oedema in the rat. J Pathol. 1974 Apr;112(4):245–262. doi: 10.1002/path.1711120409. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES